Skip to main content

Table 1 Comparison of baseline clinical characteristics and laboratory parameters of normal-BMI women with and without PCOS

From: Intra-ovarian inflammatory states and their associations with embryo quality in normal-BMI PCOS patients undergoing IVF treatment

Group

PCOS group (n = 16)

Control group (n = 16)

P

Age (years)

30.31 ± 0.84

32.19 ± 0.53

NS

BMI (kg/m2)

22.38 ± 0.42

21.81 ± 0.45

NS

Primary infertility

10 (62.50%)

15 (93.75%)

NS

Secondary infertility

6 (37.50%)

1 (6.25%)

 

Infertility years (years)

2.38 ± 0.36

2.63 ± 0.46

NS

FSH (IU/L)

5.63 ± 0.33

6.07 ± 0.39

NS

LH (IU/L)

7.11 ± 1.26

3.94 ± 0.52

0.027*

LH/FSH rate

1.14 ± 0.19

0.64 ± 0.06

0.018*

T (ng/dl)

39.99 ± 6.33

23.02 ± 3.28

0.023*

AMH (ng/ml)

8.16 ± 0.86

3.41 ± 0.34

<0.001*

WBC (109/L)

6.56 ± 0.42

5.94 ± 0.43

NS

NE (109/L)

3.87 ± 0.33

3.73 ± 0.45

NS

Lymphocytes (109/L)

2.17 ± 0.18

1.79 ± 0.18

NS

Monocytes (109/L)

0.41 ± 0.03

0.33 ± 0.02

0.030*

Ret. oocytes

29.25 ± 2.93

17.44 ± 1.85

0.002*

Rate of 2PN (%)

62.17 ± 3.58

58.10 ± 4.26

NS

D3 day high quality embryos

8.13 ± 1.33

5.06 ± 0.90

NS

Rate of D3 day quality embryo (%)

42.03 ± 4.86

54.83 ± 6.18

NS

Rate of high-quality blastocyst rate (%)

21.03 ± 6.36

28.90 ± 9.31

NS

Rate of blastocyst formation (%)

27.61 ± 5.30

34.76 ± 8.87

NS

  1. BMI, body mass index; FSH, follicle-stimulating hormone; LH, luteinizing hormone; LH/FSH, luteinizing hormone/follicle-stimulating hormone; T, testosterone; AMH, anti-Müllerian hormone; WBC, white blood cell; NE, neutrophil; Ret. oocyte, number of oocytes retrieved; 2PN, 2 pronuclear; NS, not significant
  2. Data are expressed as (means ± standard error of the mean (SEM); Count data are shown as a percentage (%); *Represents a statistically significant difference (P < 0.05)